Some people with the highest clinical need may be prescribed weight loss injections on the NHS for managing obesity.
Nottingham and Nottinghamshire Integrated Care Board issues the advice below:
‘The people below may be eligible to receive tirzepatide (Mounjaro) on the NHS. This is to ensure patients at greatest risk become eligible first:
‘People with at least 4 of the following 5 health conditions plus a BMI of at least 40 (BMI to be adjusted for ethnicity*)
- type 2 diabetes mellitus
- high blood pressure
- heart disease
- obstructive sleep apnoea (when your breathing stops and starts while you sleep)
- abnormal blood fats (dyslipidaemia)
*Due to an increased risk of heath conditions at lower BMI thresholds in the following populations, the BMI used to assess eligibility for tirzepatide will be 2.5 kg/m2 lower for people from South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean ethnic backgrounds.
You can calculate your BMI to see if you may be eligible but a full assessment will be done through a weight management service.
Find out more about weight-loss services.
